Biologic Augmentation of TMJ Arthroscopy Using BMAC
Recruiting
Phase 3
Interventional Study
TMJ - Oral &Maxillofacial Surgery
Oral and Maxillofacial Conditions
TMJ Pain
TMJ Arthralgia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn about the efficacy of using Bone Marrow Aspirate Concentrate (BMAC) during temporomandibular joint (TMJ) arthroscopy compared to standard arthroscopic procedures with corticosteroid (CS) injections in patients with pain (arthralgia) of the temporomandibular joint (TMJ) that has failed to respond to conservative treatment. The main question it aims to ans…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Participant is at least 18 years of age and not older than 75 years of age
2. Participant is willing and able to provide written informed consent to participant in this study
3. Participant has symptoms of TMJ arthralgia (pain) with significant temporomandibular joint pain an…
Contacts